Sartorius sees itself on track after a solid Q2 2025 and confirms the forecast for the full year.
📈 H1 figures at a glance:
▪️ Sales revenue: +6.1% to €1.77 billion
▪️ Adjusted EBITDA: € 527 million
▪️ Bioprocess Solutions division: +8.8%
🎯 Forecast 2025 confirmed:
▪️ Organic sales growth ~6%
▪️ Operating EBITDA margin: 29-30%
🔎 Despite global uncertainties, Sartorius remains confident.
